Abstract
Tacrine, a well-known acetylcholinesterase inhibitor, applied in concentrations higher than 2×10−5 mol/l promoted Ca2+-independent relaxation of rat gastric smooth muscles in experiments in vitro. The relaxation was not cholinergic and was a result of influence of tacrine over intracellular signaling pathways regulating smooth muscle contraction/relaxation. The nature of this untypical muscle relaxation was studied by using smooth muscle strips isolated from rat stomach. Their bioelectrical and mechanical responses were recorded after treatment with tacrine and different activators or blockers of intracellular pathways involved in muscle contractility. Following the activation of adenylate cyclase with 1×10−6 mol/l forskolin and increase in the concentration of cyclic adenosine monophosphate (cAMP) after application of 4×10−5 mol/l SQ22536, a significant decrease in the muscle relaxation was observed. Theophylline (2×10−4 mol/l), a phosphodiesterase inhibitor, had no effect on the amplitude of tacrine-induced relaxation. The latter was also reduced by inhibition of protein kinase A (PKA) with 5×10−6 mol/l KT5720. These findings support the assumption that tacrine promoted smooth muscle relaxation through PKA-induced phosphorylation and inhibition of myosin light chain kinase activity. The reduction of spike-linked Ca2+ influx provoked by tacrine was probably a secondary contributing process, associated with an influence of increased cAMP level on Ca2+ channels.
[1] Brodaty H., Tacrine in the treatment of Alzheimer’s disease, Aust. Prescr., 1996, 19, 14–17 10.18773/austprescr.1996.013Search in Google Scholar
[2] Potyk A., Treatments for Alzheimer Disease, South. Med. J., 2005, 98, 628–635 http://dx.doi.org/10.1097/01.SMJ.0000166671.86815.C110.1097/01.SMJ.0000166671.86815.C1Search in Google Scholar
[3] Summers W., Reich T., Delirium after cataract surgery: review and two cases, Am. J. Psychiatry, 1979, 136, 386–391 10.1176/ajp.1979.136.4a.386Search in Google Scholar
[4] Kosasa T., Kuriya Y., Matsui K., Yamanishi Y., Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats, Eur. J. Pharmacol., 1999, 386, 7–13 http://dx.doi.org/10.1016/S0014-2999(99)00741-410.1016/S0014-2999(99)00741-4Search in Google Scholar
[5] Hunter A., Murray T., Jones J., Cross A., Green A., The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro, Br. J. Pharmacol., 1989, 98, 79–86 10.1111/j.1476-5381.1989.tb16865.xSearch in Google Scholar
[6] Kobayashi T., Matsuno K., Nakata K., Mita S., Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain, J. Pharmacol. Exp. Ther., 1996, 279, 106–113 10.1016/0924-977X(96)88200-9Search in Google Scholar
[7] Albert A., The Acridines: Their Preparation, Physical, Chemical, and Biological Properties and Uses, Edward Arnold & Co., London, 1951 Search in Google Scholar
[8] Reiner P., McGeer E., THA increases action potential duration of central histamine neurons in vitro, Eur. J. Pharmacol., 1996, 155, 265–270 http://dx.doi.org/10.1016/0014-2999(88)90512-210.1016/0014-2999(88)90512-2Search in Google Scholar
[9] James A.N., Ryan J.P., Parkman H.P., Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility, Neurogastroenterol. Motil., 2004, 16, 143–153 http://dx.doi.org/10.1111/j.1365-2982.2004.00515.x10.1111/j.1365-2982.2004.00515.xSearch in Google Scholar PubMed
[10] Papano A.J., Cholinoceptors activating and cholinesterase inhibiting drugs, In: Katzung B.G., (Ed.), Basic & Clinical Pharmacology, 10th Ed., MacGrow-Hill, San Francisco, USA, 2006 Search in Google Scholar
[11] Turiiski V., Krustev A., Sirakov V., Getova D., In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract, Eur. J. Pharmacol., 2004, 498, 233–239 http://dx.doi.org/10.1016/j.ejphar.2004.07.05410.1016/j.ejphar.2004.07.054Search in Google Scholar PubMed
[12] Krustev A., Sirakov V., Turiiski V., Getova D., Velkova K., Prissadova N., Delayed evacuatory function due to specific smooth muscle reactivity in the gastrointestinal tracts of tacrine-treated rats, Pharmacology, 2008, 81, 50–55 http://dx.doi.org/10.1159/00010796910.1159/000107969Search in Google Scholar PubMed
[13] Turiiski V., Argirova M., Krustev A., Non-anticholinesterase, non-cholinergic effect of tacrine on gastrointestinal smooth muscle tissues of rat, Folia Med. (Plovdiv), 2005, 2, 45–52 Search in Google Scholar
[14] Krustev A., Argirova M., Getova D., Turiiski V., Prissadova N., Calcium-independent tacrine-induced relaxation of rat gastric corpus smooth muscles, Can. J. Physiol. Pharmacol., 2006, 84, 1133–1138 http://dx.doi.org/10.1139/Y06-05910.1139/Y06-059Search in Google Scholar PubMed
[15] Turiiski V., Argirova M., Prissadova N., Minkova E., Nikolov R., Terzieva D., et al., Effect of tacrine on cytosolic Ca2+ level and calmodolin in gastric muscle tissue of rat, Folia Med. (Plovdiv), 2006, 3&4, 79–85 Search in Google Scholar
[16] Kristev A., Sirakov V., Turiiski V., Getova D., Velkova K., Comparative X-ray study of galantamine and tacrine on the evacuatory function of rat gastrointestinal tract, Cent. Eur. J. Med., 2008, 3, 47–56 http://dx.doi.org/10.2478/s11536-007-0061-z10.2478/s11536-007-0061-zSearch in Google Scholar
[17] Gracon S.I., Knapp M.J., Berghoff W.G., Pierce M., DeJong R., Lobbestael S.J., et al., Safety of tacrine: clinical trials, treatment IND, and postmarketing experience, Alzheimer Dis. Assoc. Disord., 1998, 12, 93–10 http://dx.doi.org/10.1097/00002093-199806000-0000710.1097/00002093-199806000-00007Search in Google Scholar PubMed
[18] Colomer J., Schmitt A.A., Toone E.J., Means A.R., Identification and inhibitory properties of a novel Ca2+/calmodulin antagonist, Biochemistry, 2010, 49, 4244–4254 http://dx.doi.org/10.1021/bi100121310.1021/bi1001213Search in Google Scholar PubMed PubMed Central
[19] Stout M.A., Silver P.J., Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors, 1992, 153, 169–175 10.1002/jcp.1041530121Search in Google Scholar PubMed
[20] Bolton T., Aaronson P., Mackenzie I., Voltage-dependent calcium channels in intestinal and vascular smooth muscle cells, Ann. N. Y. Acad. Sci., 1998, 522, 32–42 http://dx.doi.org/10.1111/j.1749-6632.1988.tb33340.x10.1111/j.1749-6632.1988.tb33340.xSearch in Google Scholar PubMed
[21] Owens C., Cholinergic drugs and related agents. In: Block J.H., Beale J.M., (Eds), Wilson & Gisvod’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, 11th Ed., Williams & Wilkins, Lippincott, 2004 Search in Google Scholar
[22] Clinton Webb R., Smooth muscle contraction and relaxation, Adv. Physiol. Educ., 2003, 27, 201–206 10.1152/advances.2003.27.4.201Search in Google Scholar
[23] Somlyo A.V., Cyclic GMP regulation of myosin phosphatase, Circ. Res., 2007, 101, 645–647 http://dx.doi.org/10.1161/CIRCRESAHA.107.16189310.1161/CIRCRESAHA.107.161893Search in Google Scholar PubMed
[24] Gangopadhyay S.S., Barber A.L., Gallant C., Grabarek Z., Smith J.L., Morgan K.G., Differential functional properties of calmodul-independent protein kinase II gamma variants isolated from smooth muscle, Biochem. J., 2003, 372, 347–357 http://dx.doi.org/10.1042/BJ2003001510.1042/bj20030015Search in Google Scholar
[25] Zhou Z.H., Ando S.D., Furutsuka D., Ikebe M., Characterization of Ca2+/calmodulin-dependent protein kinase II from smooth muscle, Biochem. J., 1995, 310, 517–525 10.1042/bj3100517Search in Google Scholar PubMed PubMed Central
[26] Hilgers R.H.P., Webb R.C., Molecular aspects of arterial smooth muscle contraction: Focus on Rho, Exp. Biol. Med., 2005, 230, 829–835 10.1177/153537020523001107Search in Google Scholar
[27] March K.A., Characterisation of calcium/calmodulin-stimulated protein kinase. Signal transduction protocols, In: Kendall D.A., Hill S.J., (Eds.), Methods in Molecular Biology, vol. 41, Humana Press, Totowa, NJ, 1995 Search in Google Scholar
[28] Sanders K.M., G Protein-Coupled Receptors in Gastrointestinal Physiology. IV. Neural regulation of gastrointestinal smooth muscle, Am. J. Physiol. Gastrointest. Liver Physiol., 1998, 275, G1–G7 10.1152/ajpgi.1998.275.1.G1Search in Google Scholar
[29] Curley W.H., Standaert F.G., Dretchen K.L., Physostigmine inhibition of 3’,5’-cyclic AMP phosphodiesterase from cat sciatic nerve, J. Pharmacol. Exp. Ther., 1984, 228, 656–661 10.1016/0006-2952(83)90670-6Search in Google Scholar
[30] Turcato S., Clapp L.H., Effects of the adenylyl cyclase inhibitor SQ22536 on iloprost-induced vasorelaxation and cyclic AMP elevation in isolated guinea-pig aorta, Br. J. Pharmacol., 1999, 126, 845–847 http://dx.doi.org/10.1038/sj.bjp.070238310.1038/sj.bjp.0702383Search in Google Scholar
[31] Mizuno Y., Isotani F., Huang J., Ding H., Stull J.T., Kamm K.E., Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo, Am. J. Physiol., Cell Physiol., 2008, 295, C358–C364 http://dx.doi.org/10.1152/ajpcell.90645.200710.1152/ajpcell.90645.2007Search in Google Scholar
[32] White R.E., Kryman J.P., El-Mowafy A.M., Han G., Carrier G.O., cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BKCa channel activity in coronary artery smooth muscle cells, Circ. Res., 2000, 86, 897–905 10.1161/01.RES.86.8.897Search in Google Scholar
[33] Goeckeler Z.M., Wysolmerski R.B., Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation, J. Biol. Chem., 2005, 280, 33083–33095 http://dx.doi.org/10.1074/jbc.M50317320010.1074/jbc.M503173200Search in Google Scholar
[34] Etter E.F., Eto M., Wardle R.L., David L., Brautigan D.L., Murphy R.A., Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation, J. Biol. Chem., 2001, 276, 34681–34685 http://dx.doi.org/10.1074/jbc.M10473720010.1074/jbc.M104737200Search in Google Scholar
[35] Kohda Y., Gemba M., Modulation by cyclic AMP and phorbol myristate acetate of cephaloridine-induced injury in rat renal cortical slices, J. Pharmacol., 2001, 857, 54–59 10.1254/jjp.85.54Search in Google Scholar
[36] Kobayashi H., Miwa T., Nagao T., Adachi-Akahane S., Negative modulation of L-type Ca2+ channels via β-adrenoceptor stimulation in guinea-pig detrusor smooth muscle cells, Eur. J. Pharmacol., 2003, 470, 9–15 http://dx.doi.org/10.1016/S0014-2999(03)01762-X10.1016/S0014-2999(03)01762-XSearch in Google Scholar
[37] Droogmans G., Declerck I., Casteels R., Effect of adrenergic agonists on Ca2+-channel currents in single vascular smooth muscle cells, Pflugers Arch., 1987, 409, 7–12 http://dx.doi.org/10.1007/BF0058474410.1007/BF00584744Search in Google Scholar
[38] Groschner K., Schuhmann K., Baumgartner W., Pastushenko V., Schindler H., Romanin C., Basal dephosphorylation controls slow gating of L-type Ca2+ channels in human vascular smooth muscle, FEBS Lett., 1995, 373, 30–34 http://dx.doi.org/10.1016/0014-5793(95)01012-410.1016/0014-5793(95)01012-4Search in Google Scholar
[39] Dougherty J.J., Wu J., Nichols R.A., Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex, J. Neurosci., 2003, 23, 6740–6747 10.1523/JNEUROSCI.23-17-06740.2003Search in Google Scholar
© 2010 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
